Pinnacle ICAV - Antipodes Global Fund - Long - UCITS I GBP Unhedged AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 10.5 | 11.4 | |
+/-Cat | - | - | - | 1.2 | 3.0 | |
+/-B’mrk | - | - | - | 1.7 | -1.1 | |
Category: Global Large-Cap Value Equity | ||||||
Category Benchmark: Morningstar Gbl Val TME NR USD |
Key Stats | ||
NAV 20/11/2024 | GBP 12.88 | |
Day Change | 0.04% | |
Morningstar Category™ | Global Large-Cap Value Equity | |
IA (formerly IMA) Sector | Global | |
ISIN | IE0008TW19O8 | |
Fund Size (Mil) 20/11/2024 | USD 186.18 | |
Share Class Size (Mil) 20/11/2024 | GBP 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 14/02/2024 | 1.00% |
Investment Objective: Pinnacle ICAV - Antipodes Global Fund - Long - UCITS I GBP Unhedged Acc |
The aim of the Fund is to achieve absolute returns in excess of the MSCI All Country World Net Index in USD (the Index) over the investment cycle (typically 3-5 years). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jacob Mitchell 23/01/2018 | ||
Inception Date 01/07/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Not Benchmarked | Morningstar Gbl Val TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Pinnacle ICAV - Antipodes Global Fund - Long - UCITS I GBP Unhedged Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Barrick Gold Corp | Basic Materials | 3.66 |
Sanofi SA | Healthcare | 3.27 |
Capital One Financial Corp | Financial Services | 2.88 |
Merck & Co Inc | Healthcare | 2.70 |
Microsoft Corp | Technology | 2.60 |
Increase Decrease New since last portfolio | ||
Pinnacle ICAV - Antipodes Global Fund - Long - UCITS I GBP Unhedged Acc |